Precision medicine
The aim of the partnership is to research how AI can help predict cancer progression.
Also, fitness technology company GOQii has introduced an AI-powered post-organ transplant care programme.
Continuous Precision Medicine can help confirm a patient's pain medication intake so providers can better manage preventable issues, says the company's CEO and cofounder Steven Walther. However, accurate data is vital to ensuring validity.
HIMSS23
Dr. Cecil Lynch, chief medical information officer at Accenture, discusses his upcoming HIMSS23 lecture on genomics' potential impact on patient care and the importance of examining genetic information and its relationship to comorbidities.
A look ahead with Judy Jiao, CIO of National Government Services, who also gives insights on precision medicine advancements and more.
HIMSS22
Precision medicine is entering the mainstream, from genetic insights informing a range of specialties to primary care using pharmacogenomics, according to Dr. Joel Diamond of 2bPrecise.
HIMSS21
CEO and cofounder of InsightRX Sirj Goswami shares how precise dosage, determined for each patient, can improve healthcare and avoid unwanted outcomes.
2bPrecise CEO Assaf Halevy discusses how genomic information can be injected into the workflow to manage the treatment of the patient.